methylprednisolone and pci 32765

methylprednisolone has been researched along with pci 32765 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arias-Martínez, A; Carriles, C; Menárguez-Blanc, R; Ordóñez-Fernández, L; Rosado-María, MC1
Budziszewska, BK; Długosz-Danecka, M; Gil, L; Hus, M; Iskierka-Jażdżewska, E; Jamroziak, K; Jurczak, W; Lech-Marańda, E; Osowiecki, M; Piszczek, W; Puła, B; Rybka, J; Salomon-Perzyński, A; Steckiewicz, P; Subocz, E; Szukalski, Ł; Szymczyk, A; Waszczuk-Gajda, A; Zaucha, JM1

Other Studies

2 other study(ies) available for methylprednisolone and pci 32765

ArticleYear
Autoimmune hemolytic anemia, adverse event to venetoclax.
    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2019, Sep-01, Volume: 43, Issue:5

    Topics: Adenine; Aged; Anemia, Hemolytic, Autoimmune; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cyclophosphamide; Doxorubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Piperidines; Prednisone; Pyrazoles; Pyrimidines; Recurrence; Rituximab; Salvage Therapy; Sulfonamides; Vincristine

2019
Efficacy of high-dose corticosteroid-based treatment for chronic lymphocytic leukemia patients with p53 abnormalities in the era of B-cell receptor inhibitors.
    Advances in medical sciences, 2020, Volume: 65, Issue:2

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Methylprednisolone; Middle Aged; Neoplasm Recurrence, Local; Piperidines; Prognosis; Proto-Oncogene Proteins c-bcr; Purines; Quinazolinones; Retrospective Studies; Salvage Therapy; Survival Rate; Tumor Suppressor Protein p53

2020